Innocent Tesha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Innocent Tesha has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Maulid Kombo
Department of Medical Sciences, Jinzhou Medical University , Liaoning
3 shared publications - Irene Njoka
Department of Medical Sciences, Jinzhou Medical University , Liaoning
3 shared publications - Mashaka Hassan Mrisho3 shared publications
Dongqi Ye
2 shared publications- Fahad Omar Nofli2 shared publications
GangYi Wang
2 shared publications
Latest Publications
- Open Access
- 10 April 2026
- Published by Elsevier in SSRN Electronic Journal
National and subnational burden of Ischaemic stroke in Kenya from centralization to devolution, 1990–2023, with forecasts to 2033: an analysis for Global Burden Disease Study 2023
Background: Ischemic stroke burden in sub-Saharan Africa is rising, yet county-level evidence for Kenya's devolved health system remains scarce. We estimated ischemic stroke burden across Kenya's 47 counties (1990–2023) and forecasted trends to 2033 to inform decentralized policy interventions. Methods: Using GBD 2023 data, we estimated stroke incidence, prevalence, mortality, and DALYs by age, sex, and county. Joinpoint regression analyzed 1990–2023 trends (EAPC, 95% CI); ARIMA projected 2024–2033 burden. Comparative risk assessment quantified attributable factors. Findings: In 2023, Ischaemic stroke caused 11,328 deaths and 317,719 DALYs nationally. Age-standardized incidence rose slightly (EAPC 0·22%), while mortality and DALY rates declined significantly (EAPCs −0·69% and −0·45%). County-level disparities were pronounced: Kwale had the highest incidence (108·97 per 100,000), Garissa the highest mortality (46·49), and Siaya the lowest incidence (57·77). High systolic blood pressure contributed to 35% of the burden. Mortality declines accelerated after Kenya's 2013 devolution. Projections indicate mortality falling to 20–22per 100,000 by 2033, yet incidence plateauing at 85–86 per100, 000 signaling treatment gains but stalled prevention. Working-age men (40–65) experienced the highest mortality burden, though women exceeded men at ages 85+.I nterpretation: Ischaemic stroke remains a major cause of death and disability. Rising incidence alongside declining mortality signals treatment success but persistent prevention gaps. Evidence confirms devolved governance improves healthcare access and outcomes. African nations should adopt decentralized models, strengthen primary prevention, and advance universal health coverage to manage the growing disability burden.
- 10 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNational and subnational burden of Ischaemic stroke in Kenya from centralization to devolution, 1990–2023, with forecasts to 2033: an analysis for Global Burden Disease Study 2023
Background: Ischemic stroke burden in sub-Saharan Africa is rising, yet county-level evidence for Kenya's devolved health system remains scarce. We estimated ischemic stroke burden across Kenya's 47 counties (1990–2023) and forecasted trends to 2033 to inform decentralized policy interventions. Methods: Using GBD 2023 data, we estimated stroke incidence, prevalence, mortality, and DALYs by age, sex, and county. Joinpoint regression analyzed 1990–2023 trends (EAPC, 95% CI); ARIMA projected 2024–2033 burden. Comparative risk assessment quantified attributable factors. Findings: In 2023, Ischaemic stroke caused 11,328 deaths and 317,719 DALYs nationally. Age-standardized incidence rose slightly (EAPC 0·22%), while mortality and DALY rates declined significantly (EAPCs −0·69% and −0·45%). County-level disparities were pronounced: Kwale had the highest incidence (108·97 per 100,000), Garissa the highest mortality (46·49), and Siaya the lowest incidence (57·77). High systolic blood pressure contributed to 35% of the burden. Mortality declines accelerated after Kenya's 2013 devolution. Projections indicate mortality falling to 20–22per 100,000 by 2033, yet incidence plateauing at 85–86 per100, 000 signaling treatment gains but stalled prevention. Working-age men (40–65) experienced the highest mortality burden, though women exceeded men at ages 85+.I nterpretation: Ischaemic stroke remains a major cause of death and disability. Rising incidence alongside declining mortality signals treatment success but persistent prevention gaps. Evidence confirms devolved governance improves healthcare access and outcomes. African nations should adopt decentralized models, strengthen primary prevention, and advance universal health coverage to manage the growing disability burden.
- Open Access
- 17 March 2026
- Published by JMIR Publications Inc. in JMIRx Med
Factors Influencing Hemoglobin Variability and Its Prognostic Implications in Chronic Kidney Disease in dialysis patients. (Preprint)
- 17 March 2026
- Published by JMIR Publications Inc. in JMIRx Med
Open AccessFactors Influencing Hemoglobin Variability and Its Prognostic Implications in Chronic Kidney Disease in dialysis patients. (Preprint)
- Open Access
- 17 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Factors Influencing Hemoglobin Variability and Its Prognostic Implications in Chronic Kidney Disease in dialysis patients. (Preprint)
BACKGROUND Chronic Kidney Disease (CKD) is a global health burden with a high prevalence of anemia, which is largely driven by impaired erythropoiesis due to reduced erythropoietin production, iron deficiency, and chronic inflammation. Hemoglobin variability, defined as fluctuations in hemoglobin levels over time, has emerged as a key factor influencing the prognosis of CKD patients. While anemia is well-recognized in CKD, the implications of hemoglobin variability on patient outcomes, including mortality, cardiovascular events, and hospitalization, remain insufficiently explored. OBJECTIVE Primary Objectives. (1).To identify and quantify factors contributing to hemoglobin variability in CKD patients. (2).To evaluate the relationship between hemoglobin variability and prognosis, including mortality, cardiovascular outcomes, frequency of hospitalization and length of hospital stay. Secondary Objectives. (1).To explore potential strategies for minimizing hemoglobin variability in CKD patients. METHODS This retrospective cohort study aimed to identify the factors that contribute to hemoglobin variability in CKD patients and to assess its relationship with clinical outcomes. By analyzing electronic medical records (EMRs) in The First Affiliated Hospital of Jinzhou Medical University, the study evaluated data from patients with CKD stage 5, including those on dialysis, who had at least 12 months of recorded hemoglobin levels. Different factors were examined to quantify their influence on hemoglobin fluctuations. Also, the study analyzed the relationship between hemoglobin variability and outcomes . RESULTS A total of 504 participants were included. Males were 58.7% and 41.3% females. Over one third of the participants (36.9%) were elderly. Only 3.0% had a hemoglobin that remained in the normal target range (11.0 and 12.5 g/dl) at all measurements done. Majority of the participants (78.4%) had a hemoglobin that remained low (12.5 g/dl). Using the standard deviation, the median variability was 0.56 g/dl, 0.90 g/dl when using absolute range and 6.73% when using coefficient of variation. After categorizing the findings of variability, 30.0% were considered to have high variability which was defined by having variability above the upper quartile using either the standard deviation, the absolute range or the coefficient of variation. In the multivariable analysis, the independent factors contributing to hemoglobin variability in CKD patients were: age below 30 years (aOR=3.557, CI=1.522-8.314, P=0.003), diabetes mellitus (aOR=1.586, CI=1.048-2.401, P=0.029), elevated interleukin 6 (aOR=3.522, CI=1.972-6.289, P<0.001), low albumin (aOR=1.961, CI=1.257-3.060, P=0.003), high CRP (aOR=2.228, CI=1.204-4.125, P=0.011) and low ferritin levels (aOR=3.185, CI=2.019-5.025, P<0.001). Regarding prognosis, a significant association was found regarding mortality, length of hospital stays and frequency of admissions. No significant association was found regarding cardiovascular events. CONCLUSIONS Almost all participants had their Hb levels deranged from the normal target range. Patients below 30 years, those having diabetes mellitus, those with infection, low ferritin or low albumin among CKD patients should be given special attention and care as they are at a higher risk of suffering hemoglobin variation that worsens prognosis. All CKD patients with hemoglobin variability should be followed up more closely to minimize mortality and morbidity, given that it was highly associated with both outcomes .
- 17 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFactors Influencing Hemoglobin Variability and Its Prognostic Implications in Chronic Kidney Disease in dialysis patients. (Preprint)
BACKGROUND Chronic Kidney Disease (CKD) is a global health burden with a high prevalence of anemia, which is largely driven by impaired erythropoiesis due to reduced erythropoietin production, iron deficiency, and chronic inflammation. Hemoglobin variability, defined as fluctuations in hemoglobin levels over time, has emerged as a key factor influencing the prognosis of CKD patients. While anemia is well-recognized in CKD, the implications of hemoglobin variability on patient outcomes, including mortality, cardiovascular events, and hospitalization, remain insufficiently explored. OBJECTIVE Primary Objectives. (1).To identify and quantify factors contributing to hemoglobin variability in CKD patients. (2).To evaluate the relationship between hemoglobin variability and prognosis, including mortality, cardiovascular outcomes, frequency of hospitalization and length of hospital stay. Secondary Objectives. (1).To explore potential strategies for minimizing hemoglobin variability in CKD patients. METHODS This retrospective cohort study aimed to identify the factors that contribute to hemoglobin variability in CKD patients and to assess its relationship with clinical outcomes. By analyzing electronic medical records (EMRs) in The First Affiliated Hospital of Jinzhou Medical University, the study evaluated data from patients with CKD stage 5, including those on dialysis, who had at least 12 months of recorded hemoglobin levels. Different factors were examined to quantify their influence on hemoglobin fluctuations. Also, the study analyzed the relationship between hemoglobin variability and outcomes . RESULTS A total of 504 participants were included. Males were 58.7% and 41.3% females. Over one third of the participants (36.9%) were elderly. Only 3.0% had a hemoglobin that remained in the normal target range (11.0 and 12.5 g/dl) at all measurements done. Majority of the participants (78.4%) had a hemoglobin that remained low (12.5 g/dl). Using the standard deviation, the median variability was 0.56 g/dl, 0.90 g/dl when using absolute range and 6.73% when using coefficient of variation. After categorizing the findings of variability, 30.0% were considered to have high variability which was defined by having variability above the upper quartile using either the standard deviation, the absolute range or the coefficient of variation. In the multivariable analysis, the independent factors contributing to hemoglobin variability in CKD patients were: age below 30 years (aOR=3.557, CI=1.522-8.314, P=0.003), diabetes mellitus (aOR=1.586, CI=1.048-2.401, P=0.029), elevated interleukin 6 (aOR=3.522, CI=1.972-6.289, P<0.001), low albumin (aOR=1.961, CI=1.257-3.060, P=0.003), high CRP (aOR=2.228, CI=1.204-4.125, P=0.011) and low ferritin levels (aOR=3.185, CI=2.019-5.025, P<0.001). Regarding prognosis, a significant association was found regarding mortality, length of hospital stays and frequency of admissions. No significant association was found regarding cardiovascular events. CONCLUSIONS Almost all participants had their Hb levels deranged from the normal target range. Patients below 30 years, those having diabetes mellitus, those with infection, low ferritin or low albumin among CKD patients should be given special attention and care as they are at a higher risk of suffering hemoglobin variation that worsens prognosis. All CKD patients with hemoglobin variability should be followed up more closely to minimize mortality and morbidity, given that it was highly associated with both outcomes .
- Open Access
- 9 March 2026
- Published by Elsevier in SSRN Electronic Journal
Key Predictors of Undiagnosed Hypertension in Middle-Aged Adults in Tanzania: A Machine Learning Approach to Life-Course Cardiovascular Prevention
Background: Hypertension is a leading modifiable risk factor for cardiovascular disease, yet a substantial proportion of affected individuals remain undiagnosed, particularly in low-resource settings. Early detection during middle age represents a critical opportunity for life-course cardiovascular prevention. We aimed to identify key predictors of undiagnosed hypertension among middle-aged adults in Tanzania using an explainable machine learning approach.Methods: We analysed nationally representative survey data from 2,547 adults aged 40–49 years with biomarker-measured blood pressure. Undiagnosed hypertension was defined as elevated measured blood pressure without prior professional diagnosis. Analyses incorporated survey sampling weights. A random forest model was developed and compared with multivariable logistic regression. Discrimination was assessed using area under the receiver operating characteristic curve (AUC), and interpretability was examined using Shapley Additive Explanations. Stratified analyses evaluated effect modification across socioeconomic and geographic subgroups.Findings: Overall, 15·4% of participants had undiagnosed hypertension, representing 61·0% of all hypertensive individuals. The random forest model demonstrated excellent discrimination (AUC 0·945, 95% CI 0·933–0·957), substantially outperforming logistic regression (AUC 0·623, 95% CI 0·571–0·633; p<0·0001). Age and body mass index were the strongest predictors, followed by wealth index, geographic zone, and health insurance status. Marked geographic heterogeneity was observed, with Zanzibar and Northern zones exhibiting the highest predicted probabilities.Interpretation: Undiagnosed hypertension is common among Tanzanian middle-aged adults, representing a major missed opportunity for early cardiovascular risk modification. Explainable machine learning enables accurate and transparent risk stratification and may inform targeted detection strategies to reduce cardiovascular disease burden in later adulthood.
- 9 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessKey Predictors of Undiagnosed Hypertension in Middle-Aged Adults in Tanzania: A Machine Learning Approach to Life-Course Cardiovascular Prevention
Background: Hypertension is a leading modifiable risk factor for cardiovascular disease, yet a substantial proportion of affected individuals remain undiagnosed, particularly in low-resource settings. Early detection during middle age represents a critical opportunity for life-course cardiovascular prevention. We aimed to identify key predictors of undiagnosed hypertension among middle-aged adults in Tanzania using an explainable machine learning approach.Methods: We analysed nationally representative survey data from 2,547 adults aged 40–49 years with biomarker-measured blood pressure. Undiagnosed hypertension was defined as elevated measured blood pressure without prior professional diagnosis. Analyses incorporated survey sampling weights. A random forest model was developed and compared with multivariable logistic regression. Discrimination was assessed using area under the receiver operating characteristic curve (AUC), and interpretability was examined using Shapley Additive Explanations. Stratified analyses evaluated effect modification across socioeconomic and geographic subgroups.Findings: Overall, 15·4% of participants had undiagnosed hypertension, representing 61·0% of all hypertensive individuals. The random forest model demonstrated excellent discrimination (AUC 0·945, 95% CI 0·933–0·957), substantially outperforming logistic regression (AUC 0·623, 95% CI 0·571–0·633; p<0·0001). Age and body mass index were the strongest predictors, followed by wealth index, geographic zone, and health insurance status. Marked geographic heterogeneity was observed, with Zanzibar and Northern zones exhibiting the highest predicted probabilities.Interpretation: Undiagnosed hypertension is common among Tanzanian middle-aged adults, representing a major missed opportunity for early cardiovascular risk modification. Explainable machine learning enables accurate and transparent risk stratification and may inform targeted detection strategies to reduce cardiovascular disease burden in later adulthood.
- Open Access
- 3 March 2026
- Published by Oxford University Press (OUP) in The Gerontologist
- Vol. 66 (4)
Artificial Intelligence driven prediction of multiple outcomes in older adults with coronary heart disease
Background and Objectives: Frail older adults with coronary heart disease (CHD) face significantly elevated risks of adverse clinical outcomes, including mortality, prolonged hospitalizations, and frequent readmissions. Conventional risk stratification tools, inadequately account for frailty and multimorbidity, limiting their effectiveness in geriatric care. To address this gap, we developed and validated the first machine learning (ML) model that integrates frailty into a multi-outcome risk assessment framework, thereby enhancing clinical decision-making in geriatric cardiology. Research Design and Methods: Utilizing electronic health records from hospitalized frail CHD patients, we developed a multinomial prediction model employing advanced ML techniques, including principal component analysis, gradient boosting, and random forest. The model incorporates explainable artificial intelligence (AI) features to enhance interpretability and a clinical applicability, prioritizing key predictors such as biomarkers and comorbidities. Results: The ML model demonstrated superior predictive performance with receiver operating characteristic curve analysis (area under the curve 0.94, 95% CI: 0.88–1.00) for mortality, 0.72 (95% CI: 0.55–0.87) readmission, and 0.68 (95% CI: 0.57–0.77) prolonged hospital stay, enabling earlier risk identification and personalized intervention strategies. Discussion and Implications: This AI-driven approach represents a significant advancement in geriatric cardiology designed for integration into hospital dashboards, providing real-time patient-centered decision support, optimization of clinical workflow and resource allocation. By advancing digital health solutions and AI driven precision medicine, this model sets a new standard for digital health innovations in aging care.
- 3 March 2026
- Published by Oxford University Press (OUP) in The Gerontologist
- Vol. 66 (4)
Open AccessArtificial Intelligence driven prediction of multiple outcomes in older adults with coronary heart disease
Background and Objectives: Frail older adults with coronary heart disease (CHD) face significantly elevated risks of adverse clinical outcomes, including mortality, prolonged hospitalizations, and frequent readmissions. Conventional risk stratification tools, inadequately account for frailty and multimorbidity, limiting their effectiveness in geriatric care. To address this gap, we developed and validated the first machine learning (ML) model that integrates frailty into a multi-outcome risk assessment framework, thereby enhancing clinical decision-making in geriatric cardiology. Research Design and Methods: Utilizing electronic health records from hospitalized frail CHD patients, we developed a multinomial prediction model employing advanced ML techniques, including principal component analysis, gradient boosting, and random forest. The model incorporates explainable artificial intelligence (AI) features to enhance interpretability and a clinical applicability, prioritizing key predictors such as biomarkers and comorbidities. Results: The ML model demonstrated superior predictive performance with receiver operating characteristic curve analysis (area under the curve 0.94, 95% CI: 0.88–1.00) for mortality, 0.72 (95% CI: 0.55–0.87) readmission, and 0.68 (95% CI: 0.57–0.77) prolonged hospital stay, enabling earlier risk identification and personalized intervention strategies. Discussion and Implications: This AI-driven approach represents a significant advancement in geriatric cardiology designed for integration into hospital dashboards, providing real-time patient-centered decision support, optimization of clinical workflow and resource allocation. By advancing digital health solutions and AI driven precision medicine, this model sets a new standard for digital health innovations in aging care.
- Open Access
- 19 November 2025
- Published by Springer Nature in Research Square
Effectiveness of Structured Mindfulness-Based Interventions Versus Usual Care in Reducing Psychological Distress and Improving Quality of Life among Stroke patients
Background : Stroke is a leading cause of long-term disability, with survivors often experiencing significant psychological distress, including depression and anxiety, which can impact overall recovery and quality of life. Traditional rehabilitation approaches may not fully address these challenges. Mindfulness-Based Interventions (MBIs) have shown promise in managing psychological distress in stroke patients, but existing research is heterogeneous, creating gaps in evidence synthesis. Objective : This systematic review aims to evaluate the effectiveness of structured MBIs compared to usual care in reducing psychological distress and improving quality of life among stroke patients and survivors by synthesizing evidence from randomized controlled trials (RCTs). Methods : Following the PICOS framework, we conducted a systematic review of RCTs published within the last 10 years. The search strategy included multiple databases such as PubMed, PsycINFO, EMBASE, CINAHL, Web of Science, and the Cochrane Central Register of Controlled Trials. Risk of bias was assessed using the Cochrane Risk of Bias tool. Results : Eight RCTs with 587 participants were included. Interventions included MBSR, MBCT, and tailored programs like HEADS: UP. Significant improvements were observed in depression and anxiety, with large effect sizes (Cohen's d: 0.86–0.91; p < 0.05). Quality of life, cognition, sleep, motor function, and self-care also improved. Delivery methods were diverse (online, in-person, hybrid, audio-guided) with high completion rates (66.7%–99%). Conclusions : Structured MBIs can effectively reduce psychological distress and improve quality of life among stroke patients and survivors. The diverse delivery methods and adaptations highlight the potential for these interventions to be tailored to the unique needs of stroke survivors. Future research should focus on standardized reporting practices and further exploration of the mechanisms underlying the benefits of MBIs in stroke rehabilitation.
- 19 November 2025
- Published by Springer Nature in Research Square
Open AccessEffectiveness of Structured Mindfulness-Based Interventions Versus Usual Care in Reducing Psychological Distress and Improving Quality of Life among Stroke patients
Background : Stroke is a leading cause of long-term disability, with survivors often experiencing significant psychological distress, including depression and anxiety, which can impact overall recovery and quality of life. Traditional rehabilitation approaches may not fully address these challenges. Mindfulness-Based Interventions (MBIs) have shown promise in managing psychological distress in stroke patients, but existing research is heterogeneous, creating gaps in evidence synthesis. Objective : This systematic review aims to evaluate the effectiveness of structured MBIs compared to usual care in reducing psychological distress and improving quality of life among stroke patients and survivors by synthesizing evidence from randomized controlled trials (RCTs). Methods : Following the PICOS framework, we conducted a systematic review of RCTs published within the last 10 years. The search strategy included multiple databases such as PubMed, PsycINFO, EMBASE, CINAHL, Web of Science, and the Cochrane Central Register of Controlled Trials. Risk of bias was assessed using the Cochrane Risk of Bias tool. Results : Eight RCTs with 587 participants were included. Interventions included MBSR, MBCT, and tailored programs like HEADS: UP. Significant improvements were observed in depression and anxiety, with large effect sizes (Cohen's d: 0.86–0.91; p < 0.05). Quality of life, cognition, sleep, motor function, and self-care also improved. Delivery methods were diverse (online, in-person, hybrid, audio-guided) with high completion rates (66.7%–99%). Conclusions : Structured MBIs can effectively reduce psychological distress and improve quality of life among stroke patients and survivors. The diverse delivery methods and adaptations highlight the potential for these interventions to be tailored to the unique needs of stroke survivors. Future research should focus on standardized reporting practices and further exploration of the mechanisms underlying the benefits of MBIs in stroke rehabilitation.